DNA Methylation – Epigenetics Explained
DNA methylation is an epigenetic process in which methyl groups are added to DNA molecules, regulating gene activity without altering the underlying DNA sequence.
Things worth knowing about "DNA methylation"
DNA methylation is an epigenetic process in which methyl groups are added to DNA molecules, regulating gene activity without altering the underlying DNA sequence.
What is DNA Methylation?
DNA methylation is a fundamental epigenetic mechanism in which a methyl group (CH₃) is covalently attached to a DNA molecule. In mammals, this modification occurs predominantly at cytosine bases, especially at CpG dinucleotides – regions where cytosine is directly followed by guanine. This process can switch genes on or off without changing the underlying DNA sequence. The scientific field that studies such modifications is called epigenetics.
Mechanism of Action
The addition of methyl groups to DNA is catalyzed by specialized enzymes known as DNA methyltransferases (DNMTs). These are classified as:
- DNMT1: Responsible for maintenance methylation, preserving methylation patterns during cell division.
- DNMT3a and DNMT3b: Responsible for de novo methylation, establishing new methylation marks.
When DNA regions near gene promoters (known as CpG islands) are methylated, gene transcription is typically silenced. Conversely, unmethylated promoter regions are generally associated with active gene expression.
Biological Importance
DNA methylation serves a wide range of essential biological functions:
- Gene regulation: Controls gene expression during cellular development and differentiation.
- X-chromosome inactivation: In females, one of the two X chromosomes is permanently silenced through methylation.
- Genomic imprinting: Certain genes are differentially methylated depending on whether they are inherited from the mother or the father.
- Genome protection: Methylation suppresses transposable elements (transposons) that could otherwise destabilize the genome.
- Cell differentiation: During embryonic development, methylation patterns determine which genes are active in specific cell types.
DNA Methylation and Disease
Aberrant methylation patterns are associated with a wide spectrum of diseases:
Cancer
In many cancers, tumor suppressor genes are inactivated by excessive methylation (hypermethylation). At the same time, global loss of methylation (hypomethylation) can cause genomic instability and activate oncogenes. Analysis of methylation patterns is therefore increasingly used in cancer diagnostics and therapy.
Neurological Disorders
Altered DNA methylation has been observed in conditions such as Alzheimer's disease, schizophrenia, and depression, potentially affecting neuronal function and synaptic connectivity.
Developmental Disorders
Defects in methylation mechanisms can lead to genetic syndromes such as Angelman syndrome and Prader-Willi syndrome, both of which involve disrupted genomic imprinting.
Cardiovascular and Metabolic Diseases
Epigenetic changes including DNA methylation are also implicated in the development of type 2 diabetes mellitus, hypertension, and other metabolic conditions.
Factors Influencing DNA Methylation
Methylation patterns are not fixed and can be influenced by numerous external and internal factors:
- Diet: Folate, vitamin B12, methionine, and other micronutrients supply methyl groups through the one-carbon metabolism pathway.
- Environmental toxins: Heavy metals, pesticides, and air pollutants can alter methylation patterns.
- Lifestyle: Smoking, alcohol consumption, chronic stress, and physical activity all influence epigenetic marks.
- Aging: Methylation patterns change progressively with age. So-called epigenetic clocks (e.g., the Horvath clock) use these changes to estimate biological age.
Diagnostics and Clinical Applications
Advanced analytical methods such as bisulfite sequencing and DNA methylation microarrays allow precise genome-wide mapping of methylation patterns. These technologies are used for:
- Early detection of cancer through analysis of cell-free DNA in blood (so-called liquid biopsy)
- Estimation of biological age
- Diagnosis of developmental and hereditary disorders
- Companion diagnostics for epigenetically targeted therapies
Therapeutic Approaches
Because methylation changes can be reversible, they represent attractive targets for novel therapies. DNMT inhibitors (e.g., azacitidine, decitabine) are already used in the treatment of certain blood cancers, including myelodysplastic syndrome and acute myeloid leukemia. These agents inhibit DNA methyltransferases and thereby reactivate epigenetically silenced tumor suppressor genes.
References
- Allis, C. D. et al. (Eds.) - Epigenetics, 2nd Edition. Cold Spring Harbor Laboratory Press, 2015.
- Jones, P. A. - Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nature Reviews Genetics, 13(7):484-492, 2012. PubMed PMID: 22641018.
- World Health Organization (WHO) - Genomics and World Health: Report of the Advisory Committee on Health Research. WHO Press, Geneva, 2002.
Building Blocks for a Healthy Life
As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.
Verwandte Produkte
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.